Liposome formulation of peptide boronic acids compounds

Details for Australian Patent Application No. 2005304881 (hide)

Owner Alza Corporation

Inventors Martin, Francis; Zalipsky, Samuel

Agent Shelston IP

Pub. Number AU-A-2005304881

PCT Pub. Number WO2006/052734

Priority 60/625,216 05.11.04 US

Filing date 4 November 2005

Wipo publication date 18 May 2006

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052734 Priority application(s): WO2006/052734

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005304883-Message profiling systems and methods

2005304880-Liposomal formulation of bortezomib (PS-341)